Proyectos I+D+I

Project 8933-8553

Field-controlled magnetoelectric core-shell-shell nanoparticles as remote magnetic intracellular hyperthermia and on-demand drug release for targeted therapy of breast cancer cells (HIReCell)

Duration: from 01 March 2024 to 31 August 2026 (30 months) Current

183,900.00 EUR

Of European scope.

Call: (UNIÓN EUROPEA)

Leader

Leader